Herts company to appeal £5m finepublished at 12:26 Greenwich Mean Time 7 December 2016
Tom Espiner
Business reporter
Stevenage-based Flynn Pharma said the Competition and Markets Authority (CMA) was "making a serious error" and that it would appeal in a bid to overturn the watchdog's findings in regard to the overcharging for an anti-epilepsy drug.
"It beggars belief that the CMA seeks to punish Flynn for selling phenytoin capsules at a significant discount to phenytoin tablets," David Fakes of Flynn Pharma said.
Flynn Pharma and Pfizer have between 30 days and four months to reduce the price to a level acceptable to the CMA, and two months to appeal against the CMA decision to the Competition Tribunal.